In Nepal, the Department of Drug Administration has approved the use of the Chinese business Sinovac LiveScience’s “CoronaVac” vaccine. On the basis of documentation given by Sinovac’s Nepal Representative Biometrics Pvt. Ltd., the department today granted clearance for the vaccine to be used in Nepal. The Sinovac vaccine has been approved for use in Nepal, according to a departmental decision, according to Bharat Bhattarai, Director General of the Department.
The agency has already approved authorization for the Chinese Sinopharm company’s Vero Cell vaccine to be used. The vaccine, developed by Sinovac, was licensed by the World Health Organization (WHO) for emergency use earlier this year after meeting international safety, effectiveness, and productivity standards.
The WHO has approved two vaccines made in China for emergency use as a result of this. The WHO had already approved the use of Sinopharm’s Vero Cell vaccine in an emergency situation.
Sinovac’s CoronaVac vaccine was utilized in Chile, Brazil, Indonesia, Mexico, Turkey, and Thailand, among other countries. According to international media reports, more than half of individuals vaccinated in those nations exhibited no evidence of coronavirus infection, and 100% of them had no major illnesses or hospitalization.
According to the WHO, the vaccination can be given to adults above the age of 18. Sinovac’s vaccine can be kept in a regular refrigerator at a temperature of 2 to 8 degrees Celsius. In two rounds, China has distributed 1.8 million Vero Cell vaccinations to Nepal. In a similar vein, India has handed Nepal 1 million doses of the Covishield vaccine.
BK Bhandari, Director of Biometrics Pvt., stated that as soon as the vaccine was approved, an application was made for its import. Biometrics applied for import authorization from the department by setting the vaccine’s consumer price at Rs 2,100 per dosage. All costs are included in the price.”
“We asked the government and the public to join hands with us to combat the pandemic as soon as the department provided clearance for the use of the Sinovac vaccine. We’ve requested import approval so that we may get the vaccine to Nepal as quickly as possible,” he said.
He stated that they had applied for import authorization to bring 1 million vaccination doses to Nepal in the next 20 days. “We communicate with the manufacturing company on a regular basis. “The corporation has committed to distributing 1 million vaccination shots in 20 days,” Bhandari said. “After we finish all the procedures, we will bring the vaccine to Nepal in 20 days.”
He stated that talks with the relevant agencies are underway to ensure that the vaccines supplied to Nepal are distributed properly. In addition, Biometrics has constructed a storage facility in Kathmandu to house the one million immunizations.